Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical Advances in Hematology & OncologyManaging Adverse Events of Immunotherapy in Breast Cancer

Which AEs are most common with immunotherapy? Most concerning? Are some patients more likely to experience AEs? Should immunotherapy be used for patients with a pre-existing autoimmune condition? Do AEs predict response? Moffitt’s Dr. Hatem Soliman addresses these and other questions in this interview.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form